Company / Working Capital
Neogen Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$402.9M
FY2025
5-year range
$402.9M / $549.0M
FY2021-FY2025
Trend
-7.4%
vs FY2024
Sector context
#77 of 165
Health Care
What the data says
At $403M, Neogen's working capital ranks #77 of 165 in the Health Care sector. Working Capital has declined for 3 consecutive years, from $549M in FY2022 to $403M in FY2025.
Based on SEC 10-K filings.
$403M in FY2025 with a 5-year CAGR of -3.8%.
Declined from $440M to $403M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -9.8%
- 5-Year CAGR
- -3.8%
- 10-Year CAGR
- -
Sector benchmark
#77 of 165 in Health CareTop 47% of 165This company $402.9M Sector average $836.2M
▼
-51.8% below sector average
Key checks
Key Insights
- Neogen's working capital has declined for 3 consecutive years.
- 5-year CAGR of -3.8%, indicating a declining trend.
- In FY2025, working capital decreased 7.4% year-over-year.
- Ranks #77 out of 165 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $402.9M | -7.4% |
| FY2024 | $434.9M | -1.3% |
| FY2023 | $440.5M | -19.8% |
| FY2022 | $549.0M | +2.1% |
| FY2021 | $537.9M | +10.0% |
| FY2020 | $488.9M | +18.9% |
| FY2019 | $411.3M | +22.0% |
| FY2018 | $337.1M | +31.2% |
| FY2017 | $257.0M | +17.0% |
| FY2016 | $219.6M | +6.8% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026